Patents/Assignees

Hongene Biotech Corporation

15 patents in portfolio

US12180140utility2024
Compounds and Methods for Liquid Phase Oligonucleotide Synthesis
0 cites
US12134630utility2024
Compositions and Methods for Liquid Phase Oligonucleotide Synthesis
0 cites
US12116382utility2024
Functionalized N-acetylgalactosamine Analogs
0 cites
US12098371utility2024
Lipid-pegylated Compounds, Preparations and Uses Thereof
0 cites
US12092606utility2024
Compositions and Kits Comprising Interpenetrating Polymer Network for Capillary Electrophoresis
0 cites
US12065460utility2024
Compositions and Methods for Liquid Phase Oligonucleotide Synthesis
0 cites
US12065516utility2024
Polymeric Solid Support for Oligonucleotide Synthesis
0 cites
US11993626utility2024
Functionalized N-acetylgalactosamine Analogs
0 cites
US11897914utility2024
Synthesis of 2′ Protected Nucleosides
0 cites
US11884691utility2024
Functionalized N-acetylgalactosamine Analogs
0 cites
US11851454utility2023
Compositions and Methods for Liquid Phase Oligonucleotide Synthesis
0 cites
US11814450utility2023
Polymeric Solid Support for Oligonucleotide Synthesis
0 cites
US11725073utility2023
Compositions and Methods for Liquid Phase Oligonucleotide Synthesis
0 cites
US11692001utility2023
Functionalized N-acetylgalactosamine Analogs
0 cites
US11649260utility2023
Functionalized N-acetylgalactosamine Nucleosides
0 cites